Filing Details

Accession Number:
0001104659-15-066590
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-23 06:00:55
Reporting Period:
2015-09-18
Filing Date:
2015-09-23
Accepted Time:
2015-09-23 06:00:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1436304 Kythera Biopharmaceuticals Inc KYTH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559583 W John Smither C/O Kythera Biopharmaceuticals, Inc.
30930 Russell Ranch Road, 3Rd Floor
Westlake Village CA 91362
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-18 1,054 $8.22 4,422 No 4 M Direct
Common Stock Disposition 2015-09-18 1,054 $74.95 3,368 No 4 S Direct
Common Stock Acquisiton 2015-09-22 3,476 $8.22 6,844 No 4 M Direct
Common Stock Disposition 2015-09-22 3,476 $74.90 3,368 No 4 S Direct
Common Stock Acquisiton 2015-09-22 2,115 $8.22 5,483 No 4 M Direct
Common Stock Disposition 2015-09-22 2,115 $74.90 3,368 No 4 S Direct
Common Stock Disposition 2015-06-26 1,400 $0.00 6,216 No 5 G Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 5 G Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2015-09-18 1,054 $0.00 1,054 $8.22
Common Stock Stock Options Disposition 2015-09-22 3,476 $0.00 3,476 $8.22
Common Stock Stock Options Disposition 2015-09-22 2,115 $0.00 2,115 $8.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,328 2022-02-01 No 4 M Direct
852 2022-02-01 No 4 M Direct
13,272 2022-02-01 No 4 M Direct
Footnotes
  1. Shares held by the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006. John W. Smither and Noretha V. Smither, Trustees (the "1994 Smither Family Trust").
  2. 25% of the shares subject to the option vested on the first anniversary measured from January 1, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
  3. The shares subject to these options vested 100% upon the achievement of certain performance milestones approved by the Issuer's Board of Directors.